Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance

Amylx Pharmaceuticals IncTrade
Citius Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Citius Pharmaceuticals Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Amylx Pharmaceuticals Inc is far larger — about 131.9× Citius Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

AMLXCTXR
Market Cap
$2.64B$20.01M
Sector
HealthHealth
52-Week High
$24.19$1.82
52-Week Low
$7.82$0.48
Enterprise Value
$2.39B$16.23M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR